98%
921
2 minutes
20
Background: The triglyceride-glucose (TyG) related indices, indicators for insulin resistance, and depression are both established predictors of cardiovascular diseases. However, the single and combined effect of TyG related indices and depression on cardio-renal-metabolic multimorbidity (CRMM) risk remain uncertain.
Methods: This study included 7848 respondents aged 45 years and older, derived from the China Health and Retirement Longitudinal Study (CHARLS) 2011, 2020. Cox regression was used to determine independent and joint effect of TyG indices and depression on CRMM incidence. Restricted cubic spline (RCS) was further performed to identify associations of TyG indices with CRMM.
Results: Results demonstrated that both TyG indices (including TyG-WC, TyG-WHtR, and TyG-BMI) and depression were independently linked to increased risk of CRMM. The RCS model further confirmed the significant dose-response relationships. Participants experiencing both elevated TyG indices and depression exhibited the highest CRMM risk, in contrast to those with neither condition (HR = 1.630, 95%CI: 1.467-1.811; HR = 1.631, 95%CI: 1.465-1.817; HR = 1.582, 95%CI: 1.419-1.764; HR = 1.532, 95%CI: 1.372-1.711, respectively).
Limitations: Firstly, disease diagnoses in the CHARLS were self-reported, which might cause recall bias. Then, data was specific to the population over 45 years old, so the results may not apply broadly to all populations.
Conclusions: This study revealed both the single and joint effect of TyG, TyG-WC, TyG-WHtR, as well as TyG-BMI and depression on CRMM risk. Combined evaluations of the TyG index with depression screening is crucial for identifying related risk factors and enhancing prevention strategies against CRMM.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jad.2025.04.072 | DOI Listing |
Exp Gerontol
September 2025
Department of General Practice, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China. Electronic address:
Background: The triglyceride-glucose (TyG) index and its obesity-related derivatives have emerged as surrogate markers for metabolic dysfunction. This study aimed to explore their associations with glaucoma in hypertensive adults in the U.S.
View Article and Find Full Text PDFFront Nutr
August 2025
Department of Nephrology, Tianjin First Central Hospital, Tianjin, China.
Background: The triglyceride-glucose-body mass index (TyG-BMI) is a simple indicator of insulin resistance and is linked to an elevated risk of mortality. Nevertheless, limited research has explored the associations between the TyG-BMI and all-cause and cardiovascular mortality in patients undergoing peritoneal dialysis (PD).
Methods: Patients initiating PD treatment at the Tianjin First Central Hospital's Nephrology Department from July 2013 to February 2024 had triglycerides, fasting blood glucose, height, and weight measured at baseline and monthly during follow-up.
Eur J Gastroenterol Hepatol
July 2025
The First Clinical College, Hubei University of Chinese Medicine.
Background/aims: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a global health burden increasing liver-related mortality. Existing cross-sectional studies lack causal evidence between the triglyceride glucose (TyG) index and MAFLD. Utilizing data from the National Health and Nutrition Examination Survey (NHANES) 2017-2020 and Mendelian randomization, this study aimed to investigate the causal association between the TyG index and MAFLD.
View Article and Find Full Text PDFCardiovasc Diabetol
September 2025
Department of General Medicine, the 960th Hospital of People's Liberation Army Joint Logistics Support Force, NO.25 Shifan Road, Jinan, Shandong 250031, People's Republic of China.
Background: Cardiometabolic multimorbidity (CMM) imposes a progressively severe health burden worldwide. Triglyceride-glucose (TyG) index and waist-to-height ratio (WHtR), as indicators of insulin resistance and central adiposity, respectively, have been shown to be strongly associated with CMM. However, there is currently a lack of research combining the two for CMM risk assessment.
View Article and Find Full Text PDFCureus
July 2025
Department of Internal Medicine, Cantonal Hospital Zenica, Zenica, BIH.
Background Non-ST-elevation myocardial infarction (NSTEMI) is frequently associated with systemic inflammation and metabolic dysregulation. Indices derived from routine laboratory tests that reflect systemic inflammatory and lipid-inflammatory status may offer better prognostic insight. This study aimed to evaluate the association between selected indices and short-term major adverse cardiovascular events (MACE) and all-cause mortality in patients with NSTEMI treated with dual antiplatelet therapy (DAPT) and statin.
View Article and Find Full Text PDF